expert reaction to preprint from the PITCH study looking at immune response including T-cells after SARS-CoV-2 infection

A preprint, an unpublished non-peer reviewed study, looks at the immune response to COVID-19 following natural infection.   Dr Alexander Edwards, Associate Professor in Biomedical Technology, Reading School of Pharmacy, University of Reading, said: “The human immune system is beautiful and powerful.  Every individual has many ways to respond, which…

Continue Reading expert reaction to preprint from the PITCH study looking at immune response including T-cells after SARS-CoV-2 infection

New study from ISARIC 4C looking at inflammatory markers for severe and fatal COVID-19

A new study from the ISARIC 4C and UK Coronavirus Immunology Consortium teams, published this afternoon, looks at the key biological factors that characterise and distinguish severe and fatal COVID-19. The panel were able to discuss the global reach of ISARIC 4C and the importance of preparedness in a pandemic. Journalists…

Continue Reading New study from ISARIC 4C looking at inflammatory markers for severe and fatal COVID-19

New study from ISARIC 4C looking at inflammatory markers for severe and fatal COVID-19

A new study from the ISARIC 4C and UK Coronavirus Immunology Consortium teams, published this afternoon, looks at the key biological factors that characterise and distinguish severe and fatal COVID-19. The panel were able to discuss the global reach of ISARIC 4C and the importance of preparedness in a pandemic. Journalists…

Continue Reading New study from ISARIC 4C looking at inflammatory markers for severe and fatal COVID-19

expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission

The University of Oxford have posted a preprint, an unpublished non peer reviewed paper, looking at the immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and whether data says anything about transmission.    Dr Penny Ward, Visiting Professor in Pharmaceutical Medicine at King’s College London…

Continue Reading expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission

Results of UK Biobank study on how long antibodies remain post SARS-CoV-2 infection

Researchers from UK Biobank will this week report results of a major government-backed study of SARS-CoV-2 infection. The study measured the levels of previous infection in various population groups across the UK, as well as how long antibodies persisted in those who were infected. We invited journalists to hear from…

Continue Reading Results of UK Biobank study on how long antibodies remain post SARS-CoV-2 infection

expert reaction to study looking at cognitive decline in mice and a drug that reduces inflammation and boosts metabolism of macrophages

A study published in Nature looks at cognitive decline in mice when treated with a drug that reduces inflammation and boosts the metabolism of immune cells called macrophages.   Dr Susan Kohlhaas, Director of Research at Alzheimer’s Research UK, said: “This new, well-conducted study adds to existing research implicating the…

Continue Reading expert reaction to study looking at cognitive decline in mice and a drug that reduces inflammation and boosts metabolism of macrophages

expert reaction preprint looking at the early immune response to SARS-CoV-2 and how that may relate to severe and long-COVID

A preprint, an unpublished non-peer reviewed study, looks at early immune response to SARS-CoV-2 and likelihood of developing severe and ‘long’ COVID.   Prof Charles Bangham FRS FMedSci, Chair of Immunology, Imperial College London, said: “This is a very important and illuminating study.  The central findings are that an early…

Continue Reading expert reaction preprint looking at the early immune response to SARS-CoV-2 and how that may relate to severe and long-COVID

£8.4m announced for new research into COVID-19 and immunology

Three new national studies will receive £8.4 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) and bring together scientists from 17 universities across the UK to better understand immune responses to COVID-19. The scientists aim to develop better tests to define immunity and…

Continue Reading £8.4m announced for new research into COVID-19 and immunology

expert reaction to study looking at the immune response to COVID-19’s spike protein

A study, published in Nature Medicine, looked at the immune response to COVID-19’s spike protein.   Prof Mala Maini FMedSci, Wellcome Trust Senior Investigator at University College London, said: “This is an interesting and elegant study. Unlike many studies just looking at antibodies, this one looks at other important players:…

Continue Reading expert reaction to study looking at the immune response to COVID-19’s spike protein

End of content

No more pages to load